VBI Vaccines
VBIV
#10027
Rank
โ‚น0.15 B
Marketcap
โ‚น5.52
Share price
0.00%
Change (1 day)
-88.75%
Change (1 year)

Revenue for VBI Vaccines (VBIV)

Revenue in 2024 (TTM): โ‚น0.78 Billion

According to VBI Vaccines 's latest financial reports the company's current revenue (TTM ) is โ‚น0.79 Billion. In 2023 the company made a revenue of โ‚น0.72 Billion an increase over the revenue in the year 2022 that were of โ‚น89.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VBI Vaccines from 1998 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น0.78 B8.24%
2023 โ‚น0.72 B707.24%
2022 โ‚น89.53 M90.64%
2021 โ‚น46.96 M-39.47%
2020 โ‚น77.59 M-51.01%
2019 โ‚น0.15 B-32.49%
2018 โ‚น0.23 B324.74%
2017 โ‚น55.23 M48.31%
2016 โ‚น37.23 M496.14%
2015 โ‚น6.24 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2000 โ‚น3.14 M-64.96%
1999 โ‚น8.96 M5.9%
1998 โ‚น8.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.09 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น67.76 B 8,424.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.85 B 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA